12 Health Care Stocks Moving In Friday's Pre-Market Session

Loading...
Loading...

Gainers

  • Cingulate CING shares increased by 70.3% to $1.89 during Friday's pre-market session. The company's market cap stands at $21.3 million.
  • Akebia Therapeutics AKBA stock increased by 17.29% to $0.87. The company's market cap stands at $159.6 million.
  • Avinger AVGR shares moved upwards by 15.04% to $1.3. The market value of their outstanding shares is at $9.6 million.
  • CryoPort CYRX shares increased by 14.85% to $23.66. The company's market cap stands at $1.1 billion. The company's, Q4 earnings came out yesterday.
  • ASLAN Pharma ASLN stock moved upwards by 14.3% to $0.8. The market value of their outstanding shares is at $55.7 million.
  • Aditxt ADTX shares moved upwards by 11.01% to $1.31. The market value of their outstanding shares is at $5.6 million.

Losers

  • Fulcrum Therapeutics FULC shares declined by 45.7% to $7.0 during Friday's pre-market session. The market value of their outstanding shares is at $431.6 million.
  • Nektar Therapeutics NKTR shares fell 40.49% to $1.76. The market value of their outstanding shares is at $331.0 million.
  • SELLAS Life Sciences Gr SLS stock decreased by 37.4% to $2.31. The market value of their outstanding shares is at $47.5 million.
  • Ambrx Biopharma AMAM stock fell 15.01% to $5.55. The company's market cap stands at $214.3 million.
  • Applied Molecular AMTI stock decreased by 10.59% to $0.61. The company's market cap stands at $23.7 million.
  • Tactile Systems Tech TCMD stock decreased by 8.52% to $13.1. The market value of their outstanding shares is at $265.2 million. The company's, Q4 earnings came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...